Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Supplementary Materials of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9047)
All Articles published online
|
Publishing Process of This Article
|
Nov 7, 2016 (publication date) through Nov 26, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Baird AC, Mallon D, Radford-Smith G, Boyer J, Piche T, Prescott SL, Lawrance IC, Tulic MK. Dysregulation of innate immunity in ulcerative colitis patients who fail anti-tumor necrosis factor therapy. World J Gastroenterol 2016; 22(41): 9104-9116 [PMID: 27895398 DOI: 10.3748/wjg.v22.i41.9104] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i41/9104.htm |
| Number | Citing Articles |
| 1 |
Mohammed N. Khan, Majella E. Lane, Paul A. McCarron, Murtaza M. Tambuwala. Caffeic acid phenethyl ester is protective in experimental ulcerative colitis via reduction in levels of pro-inflammatory mediators and enhancement of epithelial barrier function. Inflammopharmacology 2018; 26(2): 561 doi: 10.1007/s10787-017-0364-x
|
| 2 |
Peng Chen, Gaoshi Zhou, Jingxia Lin, Li Li, Zhirong Zeng, Minhu Chen, Shenghong Zhang. Serum Biomarkers for Inflammatory Bowel Disease. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00123
|
| 3 |
Christopher G Fenton, Hagar Taman, Jon Florholmen, Sveinung W Sørbye, Ruth H Paulssen. Transcriptional Signatures That Define Ulcerative Colitis in Remission. Inflammatory Bowel Diseases 2021; 27(1): 94 doi: 10.1093/ibd/izaa075
|
| 4 |
M. V. Kruchinina, I. O. Svetlova, M. F. Osipenko, N. V. Abaltusova, A. A. Gromov, A. V. Borisova, E. V. Kruchinina. The significance of serum marker levels for assessing the status and prognosis of patients with inflammatory bowel disease. Experimental and Clinical Gastroenterology 2023; (4): 121 doi: 10.31146/1682-8658-ecg-212-4-121-132
|
| 5 |
Sabine Ivison, Christine Des Rosiers, Sylvie Lesage, John D Rioux, Megan K Levings. Biomarker-guided stratification of autoimmune patients for biologic therapy. Current Opinion in Immunology 2017; 49: 56 doi: 10.1016/j.coi.2017.09.006
|
| 6 |
Duaa Ahmed Elhag, Manoj Kumar, Marwa Saadaoui, Anthony K. Akobeng, Fatma Al-Mudahka, Mamoun Elawad, Souhaila Al Khodor. Inflammatory Bowel Disease Treatments and Predictive Biomarkers of Therapeutic Response. International Journal of Molecular Sciences 2022; 23(13): 6966 doi: 10.3390/ijms23136966
|
| 7 |
Fereshte Abdolmaleki, Najmeh Farahani, Seyed Mohammad Gheibi Hayat, Matteo Pirro, Vanessa Bianconi, George E. Barreto, Amirhossein Sahebkar. The Role of Efferocytosis in Autoimmune Diseases. Frontiers in Immunology 2018; 9 doi: 10.3389/fimmu.2018.01645
|
| 8 |
Javier P Gisbert, María Chaparro. Predictors of Primary Response to Biologic Treatment [Anti-TNF, Vedolizumab, and Ustekinumab] in Patients With Inflammatory Bowel Disease: From Basic Science to Clinical Practice. Journal of Crohn's and Colitis 2020; 14(5): 694 doi: 10.1093/ecco-jcc/jjz195
|
| 9 |
Toer W. Stevens, Mijntje Matheeuwsen, Maria H. Lönnkvist, Claire E. Parker, Manon E. Wildenberg, Krisztina B. Gecse, Geert R. D’Haens. Systematic review: predictive biomarkers of therapeutic response in inflammatory bowel disease—personalised medicine in its infancy. Alimentary Pharmacology & Therapeutics 2018; 48(11-12): 1213 doi: 10.1111/apt.15033
|
| 10 |
Federica Giachero, Andreas Jenke, Matthias Zilbauer. Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Review of Clinical Immunology 2021; 17(8): 871 doi: 10.1080/1744666X.2021.1945442
|
| 11 |
A. Lekic, Z. Brekalo, A. Kvesic, M. Kovacevic, Z. Baricev‐Novakovic, I. Sutic, A. Bulog, I. Sutic, V. Pavisic, I. Mrakovcic‐Sutic. Crosstalk Between Enzyme Matrix Metalloproteinases 2 and 9 and Regulatory T Cell Immunity in the Global Burden of Atherosclerosis. Scandinavian Journal of Immunology 2017; 86(1): 65 doi: 10.1111/sji.12563
|
| 12 |
Jian Shen, Jiazheng Cheng, Shengguo Zhu, Jun Zhao, Qingyan Ye, Yinyin Xu, Huilin Dong, Xianhui Zheng. Regulating effect of baicalin on IKK/IKB/NF-kB signaling pathway and apoptosis-related proteins in rats with ulcerative colitis. International Immunopharmacology 2019; 73: 193 doi: 10.1016/j.intimp.2019.04.052
|
| 13 |
Wanling Li, Yaqing Huang, Jun Liu, Yue Zhou, Hongyu Sun, Yonghong Fan, Feila Liu. Defective macrophage efferocytosis in advanced atherosclerotic plaque and mitochondrial therapy. Life Sciences 2024; 359: 123204 doi: 10.1016/j.lfs.2024.123204
|
| 14 |
Ki-Uk Kim, Jisu Kim, Wan-Hoon Kim, Hyeyoung Min, Chang Hwan Choi. Treatments of inflammatory bowel disease toward personalized medicine. Archives of Pharmacal Research 2021; 44(3): 293 doi: 10.1007/s12272-021-01318-6
|
| 15 |
Yun Ge, Man Huang, Yong-ming Yao. Efferocytosis and Its Role in Inflammatory Disorders. Frontiers in Cell and Developmental Biology 2022; 10 doi: 10.3389/fcell.2022.839248
|
| 16 |
Sophie Vieujean, Edouard Louis. Precision medicine and drug optimization in adult inflammatory bowel disease patients. Therapeutic Advances in Gastroenterology 2023; 16 doi: 10.1177/17562848231173331
|
| 17 |
Tim Raine, Bram Verstockt, Uri Kopylov, Konstantinos Karmiris, Rimma Goldberg, Raja Atreya, Johan Burisch, John Burke, Pierre Ellul, Charlotte Hedin, Stefan D Holubar, Konstantinos Katsanos, Triana Lobaton, Carsten Schmidt, Garret Cullen. ECCO Topical Review: Refractory Inflammatory Bowel Disease. Journal of Crohn's and Colitis 2021; 15(10): 1605 doi: 10.1093/ecco-jcc/jjab112
|
| 18 |
Hiroshi Nakase, Noriko Sato, Naomi Mizuno, Yoshiko Ikawa. The influence of cytokines on the complex pathology of ulcerative colitis. Autoimmunity Reviews 2022; 21(3): 103017 doi: 10.1016/j.autrev.2021.103017
|
| 19 |
Yue Zhang, Takeshi Yamamoto, Shusaku Hayashi, Makoto Kadowaki. Suppression of plasmacytoid dendritic cell migration to colonic isolated lymphoid follicles abrogates the development of colitis. Biomedicine & Pharmacotherapy 2021; 141: 111881 doi: 10.1016/j.biopha.2021.111881
|
| 20 |
Raja Atreya, Markus F. Neurath, Britta Siegmund. Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?. Frontiers in Medicine 2020; 7 doi: 10.3389/fmed.2020.00517
|